190 related articles for article (PubMed ID: 18687447)
1. Acute promyelocytic leukemic involvement of the optic nerves following mitoxantrone treatment for multiple sclerosis.
Ko MW; Tamhankar MA; Volpe NJ; Porter D; McGrath C; Galetta SL
J Neurol Sci; 2008 Oct; 273(1-2):144-7. PubMed ID: 18687447
[TBL] [Abstract][Full Text] [Related]
2. Acute promyelocytic leukemia after mitoxantrone therapy for multiple sclerosis.
Ramkumar B; Chadha MK; Barcos M; Sait SN; Heyman MR; Baer MR
Cancer Genet Cytogenet; 2008 Apr; 182(2):126-9. PubMed ID: 18406875
[TBL] [Abstract][Full Text] [Related]
3. Mitoxantrone-related acute leukemia in two MS patients.
Pielen A; Goffette S; Van Pesch V; Gille M; Sindic CJ
Acta Neurol Belg; 2008 Sep; 108(3):99-102. PubMed ID: 19115673
[TBL] [Abstract][Full Text] [Related]
4. Therapy-related acute nonlymphoblastic leukemia following mitoxantrone therapy in a patient with multiple sclerosis.
Sumrall A; Dreiling B
J Miss State Med Assoc; 2007 Jul; 48(7):206-7. PubMed ID: 17939254
[TBL] [Abstract][Full Text] [Related]
5. A case of acute promyelocytic leukaemia following mitoxantrone treatment of multiple sclerosis.
Cattaneo C; Almici C; Borlenghi E; Motta M; Rossi G
Leukemia; 2003 May; 17(5):985-6. PubMed ID: 12750718
[No Abstract] [Full Text] [Related]
6. Revision of the risk of secondary leukaemia after mitoxantrone in multiple sclerosis populations is required.
Pascual AM; Téllez N; Boscá I; Mallada J; Belenguer A; Abellán I; Sempere AP; Fernández P; Magraner MJ; Coret F; Sanz MA; Montalbán X; Casanova B
Mult Scler; 2009 Nov; 15(11):1303-10. PubMed ID: 19825889
[TBL] [Abstract][Full Text] [Related]
7. Acute promyelocytic leukemia in a patient with multiple sclerosis following treatment with mitoxantrone.
Novoselac AV; Reddy S; Sanmugarajah J
Leukemia; 2004 Sep; 18(9):1561-2. PubMed ID: 15215874
[No Abstract] [Full Text] [Related]
8. Four new cases of therapy-related acute promyelocytic leukemia after mitoxantrone.
Bosca I; Pascual AM; Casanova B; Coret F; Sanz MA
Neurology; 2008 Aug; 71(6):457-8. PubMed ID: 18678830
[No Abstract] [Full Text] [Related]
9. Two new cases of acute promyelocytic leukemia following mitoxantrone treatment in patients with multiple sclerosis.
Ledda A; Caocci G; Spinicci G; Cocco E; Mamusa E; La Nasa G
Leukemia; 2006 Dec; 20(12):2217-8. PubMed ID: 17051242
[No Abstract] [Full Text] [Related]
10. Chronic myeloid leukemia associated with mitoxantrone treatment in a patient with MS.
Sadiq SA; Rammal M; Sara G
Mult Scler; 2008 Mar; 14(2):272-3. PubMed ID: 17986509
[TBL] [Abstract][Full Text] [Related]
11. [Acute heart failure in a patient treated by mitoxantrone for multiple sclerosis].
Feuillet L; Guedj E; Eusebio A; Malikova I; Pelletier J; Mundler O; Ali Chérif A;
Rev Neurol (Paris); 2003 Dec; 159(12):1169-72. PubMed ID: 14978418
[TBL] [Abstract][Full Text] [Related]
12. [Mitoxantrone for the treatment of patients with multiple sclerosis].
Komori M; Kondo T; Tanaka M
Brain Nerve; 2009 May; 61(5):575-80. PubMed ID: 19514518
[TBL] [Abstract][Full Text] [Related]
13. Risk of acute promyelocytic leukemia in multiple sclerosis: coding variants of DNA repair genes.
Hasan SK; Buttari F; Ottone T; Voso MT; Hohaus S; Marasco E; Mantovani V; Garagnani P; Sanz MA; Cicconi L; Bernardi G; Centonze D; Lo-Coco F
Neurology; 2011 Mar; 76(12):1059-65. PubMed ID: 21346221
[TBL] [Abstract][Full Text] [Related]
14. [Mitoxantrone].
Pericot I; Montalban X
Neurologia; 2003; 18(6):318-23. PubMed ID: 12838451
[TBL] [Abstract][Full Text] [Related]
15. Study of mitoxantrone for the treatment of recurrent neuromyelitis optica (Devic disease).
Weinstock-Guttman B; Ramanathan M; Lincoff N; Napoli SQ; Sharma J; Feichter J; Bakshi R
Arch Neurol; 2006 Jul; 63(7):957-63. PubMed ID: 16831964
[TBL] [Abstract][Full Text] [Related]
16. Therapy-related acute leukaemia with Mitoxantrone: what is the risk and can we minimise it?
Ellis R; Boggild M
Mult Scler; 2009 Apr; 15(4):505-8. PubMed ID: 19251838
[TBL] [Abstract][Full Text] [Related]
17. Tolerability and acceptance of prolonged low/delayed mitoxantrone regimens in patients with worsening multiple sclerosis.
Zecca C; Petrini L; Limoni C; Staedler C; Gobbi C
Eur Neurol; 2011; 65(1):40-5. PubMed ID: 21196739
[TBL] [Abstract][Full Text] [Related]
18. Acute promyelocytic leukemia following mitoxantrone as single agent for the treatment of multiple sclerosis.
Vicari AM; Ciceri F; Folli F; Lanzi R; Colombo B; Comi G; Camba L
Leukemia; 1998 Mar; 12(3):441-2. PubMed ID: 9529141
[No Abstract] [Full Text] [Related]
19. Therapy-related acute leukemia in two patients with multiple sclerosis treated with Mitoxantrone.
Colovic N; Suvajdzic N; Kraguljac Kurtovic N; Djordjevic V; Dencic Fekete M; Drulovic J; Vidovic A; Tomin D
Biomed Pharmacother; 2012 Apr; 66(3):173-4. PubMed ID: 22440894
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic role of mitoxantrone in multiple sclerosis.
Neuhaus O; Kieseier BC; Hartung HP
Pharmacol Ther; 2006 Jan; 109(1-2):198-209. PubMed ID: 16095713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
